FDA Approved: NUEDEXTA — Supplemental Application (Otsuka America Pharmaceutical, Inc)

View source ↗

Summary

The FDA approved a supplemental application for NUEDEXTA (dextromethorphan hydrobromide and quinidine sulfate) submitted by Otsuka America Pharmaceutical, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudobulbar Affect

Drugs mentioned

• NUEDEXTA (DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE)

Snippet

SUPPL AP for NUEDEXTA (DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE)